Presenter: John Spertus, MD
Professor, Daniel J. Lauer Missouri Endowed Chair in Metabolism and Vascular Disease Research
University of Missouri-Kansas City
John Spertus, MD, MPH, FACC, is a cardiologist and the Lauer/Missouri Endowed Chair and Tenured Professor of Medicine at the University of Missouri-Kansas City where he serves as Director of Outcomes Research at the Mid America Heart Institute. He is a graduate of UCSF Medical School and completed his internal medicine, cardiology and health services training at the University of Washington. Dr. Spertus’ research has focused upon the methodology of patient-centered outcomes assessment and the quantification of healthcare quality. He developed the Seattle Angina Questionnaire (SAQ), and the Kansas City Cardiomyopathy Questionnaire (KCCQ), which have both been translated into over 40 languages and are emerging as the gold standards for quantifying patients’ symptoms, function and quality of life in coronary artery disease and heart failure. These instruments have been successfully used as endpoints in clinical trials, as markers of healthcare quality and as tools for improving patient care.
Dr. Spertus assists numerous governmental and industry trials in the design and analysis of patient-centered outcomes. Dr. Spertus has held continuous NIH support for his research since 1999 and was recently awarded an NHLBI SCCOR grant in conjunction with Washington University, to pursue a translational research program describing the etiology of disparities in outcomes among minority patients and to identify the mechanisms for diabetic patients’ adverse prognosis after an acute myocardial infarction. Dr. Spertus is extremely committed to the evaluation and improvement in the quality of cardiovascular care and in related applications of outcomes research. He has served on numerous national committees for the American College of Cardiology, American Heart Association, American Medical Association, National Quality Forum, United Healthcare and Blue Cross/Blue Shield. He has also founded the Cardiovascular Outcomes Research Consortium and CV Outcomes (www.cvoutcomes.org); a non-profit 501(c)(3) corporation dedicated to the advancement of healthcare quality and outcomes research in cardiovascular disease.
Presenters:
William Fearon, MD, Professor of Medicine – Stanford
David Maron, MD, Clinical Professor of Medicine – Stanford
William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Medicine (Cardiology) and Director of Interventional Cardiology at Stanford University. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology and the Society of Cardiovascular Angiography and Interventions. He was elected to the American Society of Clinical Investigation.
Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and is a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He has presented and published a number of abstracts and peer-reviewed papers in this area, and serves on the editorial board of Circulation, the Journal of the American College of Cardiology, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He is the principal investigator on an R01 award from the NIH evaluating cardiac allograft vasculopathy. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement.
David Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014.
Presenter: Andrew Chang, MD
Clinical Instructor, General Medical Disciplines
Stanford University
Presenter: Libo Wang ,MD
Resident, Internal Medicine
Stanford University
Andrew Chang, MD, is a Chief Resident / Clinical Instructor at Stanford University School of Medicine. Graduate of Stanford Internal Medicine / Global Health residency program. His professional interests include epidemiology, qualitative research, and health economics. Chang’s long-term interests include developing and researching appropriate technologies and innovations for use in low-resource settings, with an emphasis on design thinking and social justice. Areas of application include non-communicable diseases and cardiovascular conditions. Other formal training includes bench and translational research background in immunology, cancer biology, and neuroscience.
Libo Wang, MD, is a resident physician in internal medicine at Stanford.
Presenter: Richard Popp, MD
Professor (Emeritus), Cardiovascular Medicine
Stanford University
Richard Popp, MD, is Professor of Medicine (Emeritus) at Stanford University. He received his undergraduate and medical degrees, and performed internship and residency, at Johns Hopkins. He did further clinical and research training in Cardiology at Indiana University Medical Center and at Stanford, returning to the Stanford faculty in 1971 after military service. Dr. Popp began his career as an “invasive” cardiologist but he focused his research on developing non-invasive methods for medical diagnosis and therapy. He has authored over 270 publications and has been a pioneer in the development of ultrasound in cardiology. He worked with several companies to build their first phased array two-dimensional ultrasonic imaging instruments.
Dr. Popp was President of the American College of Cardiology, The American Society of Echocardiography and The Association of University Cardiologists. He was Chairman of the American Board of Internal Medicine’s (ABIM) Cardiovascular Diseases Subspecialty Board and was on the Executive Committee and the Board of Governors of the ABIM. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Popp maintains a continuing interest in technology development for improved patient care. He has made significant contributions to the continuous improvement of ultrasonic diagnostic methods by several companies in areas including two-dimensional and three-dimensional echocardiography, Doppler ultrasound, color flow imaging, trans-esophageal and contrast echocardiography. He was one of the first to employ intravascular ultrasonic imaging. Dr. Popp was Senior Associate Dean for Academic Affairs at Stanford University School of Medicine and an early member of the Biodesign faculty. Since retirement from the full-time faculty he continues his chairmanship of the Conflict of Interest Committee at the School of Medicine. He has been a Venture Partner at Advanced Technology Ventures and an Advisor to Lightstone Ventures. He is on the Board of Directors of several private companies and heads the Medical Advisory Board of other companies.
Presenters: David Maron, MD, and William Fearon, MD
Maron: Clinical Professor of Cardiovascular Medicine, Director of Preventive Cardiology
Fearon: Professor of Cardiovascular Medicine, Director of Interventional Cardiology
Stanford University
David Maron, MD
Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014.
William Fearon, MD
Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Medicine (Cardiology) and Director of Interventional Cardiology at Stanford University. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology and the Society of Cardiovascular Angiography and Interventions. He was elected to the American Society of Clinical Investigation.
Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and is a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He has presented and published a number of abstracts and peer-reviewed papers in this area, and serves on the editorial board of Circulation, the Journal of the American College of Cardiology, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He is the principal investigator on an R01 award from the NIH evaluating cardiac allograft vasculopathy. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement.
Presenter: Ian Meredith, MD, PhD, AM
Global Chief Medical Officer, Executive Vice President
Boston Scientific Corporation
Ian Meredith, M.D., Ph.D., AM, has been the Global Chief Medical Officer and Executive Vice President of Boston Scientific Corporation since January 2017. Meredith serves as Medical Venture Partner and Advisor at BioStar Ventures LLC. He is the Director of MonashHeart, Monash Health and Professor of Medicine and Cardiology at Monash University in Melbourne, Australia. He also is Executive Director of the Monash Cardiovascular Research Centre, Monash Health.
The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff. We have invited Connor O’Brien, MD, research fellow in Cardiovascular Medicine and a highly experienced cardiology educator, to provide you with a solid foundation in the basics of ECG interpretation. Additionally, Kiera Davis, RN, BSN, will be conducting a tutorial on proper 12-lead ECG electrode placement.
Click HERE to register!
At the conclusion of this class, you will be able to:
- Identify heart structures
- Describe the conduction system of the heart
- Identify ECG morphology
- Interpret basic ECGs
- Perform proper ECG electrode placement
- Describe the rationales for ECG use
Attendance is open to all research staff
About the Instructors:
Connor O’Brien, MD, is currently completing a research fellowship, after completing his fellowship in Cardiovascular Medicine at Stanford University. He obtained his medical degree from Columbia University and his BA in Biology and Biological Basis of Behavior from the University of Pennsylvania. Connor has received multiple teaching awards including the Timothy F. Becket Jr. Award for Best Clinical Teaching by a Medicine fellow in 2016 and Best Clinical Fellow in the Division of Cardiovascular Medicine in 2017.
Kiera Davis, RN, BSN, began her career at Duke University as a clinical research coordinator in the Department of Pulmonary and Critical Care Medicine. She then attended Duke University School of Nursing, obtaining her Bachelor of Science in Nursing from the Accelerated BSN program. From 2011-2015, she worked as a pediatric cardiac ICU nurse, caring for pre- and post-surgical cardiac patients. She was a member of the education committee at Duke University in the pediatric cardiac ICU, training nursing students and new nursing graduates. She joined the Stanford Center for Clinical Research is 2015 and is the Education Program Manager, facilitating and developing training for clinical research staff across the Department of Medicine and Stanford affiliated sites.
BRN OPTIONAL
Spectrum is an approved provider by the California Board of Registered Nursing, Provider Number CEP15435 for 2 contact hour(s).
To receive your certificate with BRN credit, you are required to complete an evaluation at the conclusion of this class.
BRN Cancellation Policy: If you wish to cancel your registration, please contact the course coordinator, Kiera Davis at klarsen5@stanford.edu.
Arthur L. Bloomfield Professor of Medicine
Cardiovascular Institute
Stanford University Medical Center
Dr. Robert A. Harrington is an interventional cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chairman of the Department of Medicine at Stanford University. Dr. Harrington was previously the Richard Sean Stack, MD Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes, building local, national and international collaborations for the efficient conduct of innovative clinical research and trying to better understand and improve upon the methodology of clinical research. His research has been extensively funded through NIH, NIA, other peer reviewed agencies and private industry. Committed to training and mentorship, Harrington has served as the principal mentor for more than 20 post-doctoral clinical research fellows focused on cardiovascular research.
He has authored more than 640 peer-reviewed manuscripts, reviews, book chapters, and editorials. Thomson Reuters lists him as one of the most cited investigators in clinical medicine from 2002-2014. He is a deputy editor of JAMA Cardiology and an editorial board member for the Journal of the American College of Cardiology. He has served as editor of five textbooks and is a senior editor of the 13th and 14th editions of Hurst’s The Heart, one of the leading textbooks of cardiovascular medicine. He has been a member of the NHLBI’s Clinical Trials Study Section and the IOM’s Working Group on Data Sharing. He served as a member of the NIH NCATS Advisory Council Working Group on the IOM CTSA Program. He recently served a second term as a member and the chair of the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.
Harrington was recently a member of the American College of Cardiology (ACC) Board of Trustees and is currently a member of the American Heart Association’s (AHA) Board of Directors, its Science Advisory and Coordinating Committee, and its President-elect. He will serve as the AHA President beginning in July 2019. He served as the Chair for the AHA’s Scientific Sessions in 2013 and 2014. Harrington is a Fellow of the American College of Cardiology, the American Heart Association, the Society for Cardiac Angiography and Intervention, the European Society of Cardiology, the American College of Chest Physicians and the American College of Physicians. He is an elected member of the Association of American Physicians and the Association of University Cardiologists. In 2015, he was elected to membership in the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology. He was awarded the AHA’s Clinical Research Prize in 2017.
Harrington received his BA in English at the College of the Holy Cross, Worcester, MA. He attended Dartmouth Medical School and received his MD from Tufts University School of Medicine, Boston MA. He did his internship, residency and served as the chief resident in internal medicine at the University of Massachusetts Medical Center, Worcester MA. He trained in cardiology, interventional cardiology and clinical research (Duke Databank for Cardiovascular Disease) at Duke University Medical Center, Durham NC where he was a faculty member from 1993-2012 before joining the Stanford University faculty in 2012. Interested in innovative learning tools, including novel methods of communicating scientific information, Harrington hosts a regular podcast on theheart.org, The Bob Harrington Show, and can be followed on Twitter @HeartBobH.
Presenter: Eric Velazquez, MD
Robert W. Berliner Professor of Cardiology; Chief, Cardiovascular Medicine, Yale University
Eric Jose Velazquez, MD, newly named as the Robert W. Berliner Professor of Cardiology, is globally recognized as an authority in heart failure, cardiovascular clinical trials, and cardiac imaging.
Velazquez is a clinician-investigator whose major contributions to science include the design, development, and implementation of landmark, randomized clinical trials that have altered international guidelines and the treatment of patients with chronic heart failure, particularly those with concomitant coronary artery disease. With his Duke colleagues and over 100 centers worldwide, Velazquez led the Surgical Treatment of Ischaemic Heart Failure Trial. The program defined the role for coronary artery bypass grafting in increasing survival of patients with heart failure with reduced ejection fraction.
NOTE: This MGR is ONLINE-only.
AGENDA
Feature Presentation: Structural Interventions in Cardiology
Presenter:
- Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Healthcare and Clinical Assistant Professor of Medicine at Stanford University
CME Accreditation:
To Claim CME Credit, Click here and enter the Activity ID: 37408
Disclosure Information is found here.